An independent source of information on U.S. brand name drugs for health professionals

Drugdocs Logo

An independent source of information on U.S. brand name drugs for health professionals

HomeDrugsGlossaryAboutContact Us

Menu

HomeDrugsGlossaryAboutContact Us

Drugs A-Z

ABCDE FGHIJKLMNOPQRSTUVWXYZ

DRUGS

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Omegaven

Chemical Namefish oil triglycerides
Dosage FormInjection (intravenous; 5 g/50 mL, 10 g/100 mL)
Drug ClassMiscellaneous
SystemDigestive
CompanyFresenius Kabi USA LLC
Approval Year2018

Indication

  • To treat parenteral nutrition-associated cholestasis.
Last updated on 11/2/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Omegaven (fish oil triglycerides) Prescribing Information 2018Fresenius Kabi USA LLC, Grand Island, NY
Document TitleYearSource
Lipid emulsions for parenterally fed term and late preterm infants. 2019Cochrane Database of Systematic Reviews
Parenteral fish oil-containing lipid emulsions may reverse parenteral nutrition-associated cholestasis in neonates: a systematic review and meta-analysis. 2015The Journal of Nutrition